Evaluation of IFN-γ levels in patients with bone tumors has been limited, but a mechanistic study suggests that IFN-γ induced the growth of HOS-Y1 osteosarcoma cells through activation of growth factors30. This evidence concerns the gene IFNG and osteosarcoma.